Cargando…
Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study
OBJECTIVE: To assess the risk of select safety outcomes including endometrial cancer, endometrial hyperplasia, and breast cancer among women using conjugated estrogens/bazedoxifene (CE/BZA) as compared with estrogen/progestin combination hormone therapy (EP). METHODS: We conducted a new-user cohort...
Autores principales: | Hoffman, Sarah R., Governor, Samuel, Daniels, Kimberly, Seals, Ryan M., Ziyadeh, Najat J., Wang, Florence T., Dai, Dingwei, Mcmahill-Walraven, Cheryl N., Shuminski, Patty, Frajzyngier, Vera, Zhou, Xiaofeng, Shen, Rongjun, Garg, Renu K., Fournakis, Nicole, Lanes, Stephan, Beachler, Daniel C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389232/ https://www.ncbi.nlm.nih.gov/pubmed/37449720 http://dx.doi.org/10.1097/GME.0000000000002217 |
Ejemplares similares
-
The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause
por: Lello, Stefano, et al.
Publicado: (2017) -
Bazedoxifene/conjugated estrogens in combination with leuprolide for the treatment of endometriosis
por: Hill, Amanda M., et al.
Publicado: (2018) -
Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
por: Noirrit, Emmanuelle, et al.
Publicado: (2019) -
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
por: Rossini, Maurizio, et al.
Publicado: (2013) -
Update on bazedoxifene: A novel selective estrogen receptor modulator
por: Biskobing, Diane M
Publicado: (2007)